Walt Disney Panel Van Vehicle is Seen on The Second TV Camera in The Nevada Fake Moon Bay.
This Video As You Hear & See it, From NASA's Public Domain Movie:
Apollo 16: Nothing So Hidden (1972)
Music- Swan Lake Suite OP 20
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
Bilim Karşısındaki Engelleri Aşmak (Break the Science Barrier) - Bölüm 1
Richard Dawkins bilim alanında tanıdık bir isim. Çok satan bir dizi kitabı, Gen Bencildir, Kör Saatçi ve Olasılıksızlık Dağına Tırmanmak (Kuzey Yayınları tarafından Türkçe'ye çevriliyor) ile evrim hakkındaki bakışımızı değiştirdi. Bu yıl (1995) Bilimin Halkça Anlaşılması kürsüsünün ilk Oxford'lı profesörü oldu. Şimdi de bilime bakışımızı değiştirmek istiyor.
Bu çok ağır bir top. Gerçek bir gülleden daha ağır çünkü dayanıklı kurşundan yapıldı. İnsan kafasından on kat daha ağır. Şimdi sizden istediğim bu noktaya doğru gitmeniz, topu burnunuza doğru tutmanız. Topu bırakın ve aynı noktada durun. Newton'ın enerji korunumu kanunu nedeniyle bu topun burnunuzun ucunda aniden durup size zarar vermeyeceğinden emin olabilirsiniz. Şu anda bu deneye katılmak isteyen gönüllü var mı?
O halde kendim yapmak durumundayım.
Asıl sorun bilimin doğal hayatımızın bir parçası olmamasıdır. Hepimiz bu deneyde bir tehlike olmadığını bilmeliyiz. Bilimin bize böyle söylediğini bilmeliyiz. Ancak belli ki hepimiz böyle yapmıyoruz. Benim bu programdaki amacım ise bilimin hayatımızda neden önemli bir yer tutması gerektiğini göstermek.
Bilime sırtımızı döndüğümüz ve bilim karşıtlığını kucakladığımız an, yüzyüze kalacağımız tehlikeleri göstermeyi umuyorum. Ve bilimin ne yapabileceğini anlamadan alacağımız riskleri...
Başlamak için en uygun yer her şeyin başlangıcına gitmek olacak. Evrenin kökeni hakkında bilmediğimiz çok şey var ve araştırmaya devam etmeliyiz. Fakat evrimsel yaşamın büyük resmi hiç şüpheye yer bırakmayacak şekilde ortaya çıkmıştır.
Dünya yaklaşık 4.5 milyar yaşında. Ve kısa bir süre sonra, ilk bir milyar yılda ilk canlı hücreler ortaya çıktı ve bunun ardından hepimiz türedik, tüm bitkiler, tüm hayvanlar, tüm insanlar...
Bu kanıtlanmış bir olgudur. Tüm canlılar hepimiz kuzeniz. Bilim insanları bunu, dünyanın düz değil, yuvarlak olması veya Dünya'nın diğer şekilde değil de Güneş'in etrafında dönmesi gibi kabul ederler. Buna inanmamak gülünç olur.
Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
In the noisy, contradictory health-help arena, Food & Fitness After 50 gives readers simple and straightforward tools to eat well, move well and be well after 50.
The new title from the Academy of Nutrition and Dietetics counters ever-changing nutrition and fitness advice by untangling myths, answering vexing questions and simplifying science and research so readers can chart a clear, personalized pathway to enhanced health.
“Many people fall into habits that seem hard to change, but with a bit of planning and the realization that health matters, anyone can make meaningful changes to eat well, move well and be well at any age,” according to Food & Fitness After 50 co-authors Christine Rosenbloom, PhD, RDN, FAND, and Bob Murray, PhD, FACSM.
Divided into three sections that focus on diet, exercise and overall wellness, Food & Fitness After 50 translates scientific research into simple, actionable steps to control food choices and fitness strategies for adults in their 50s, 60s, 70s and beyond.
To view the multimedia release go to:
https://www.multivu.com/players/English/8191551-academy-of-nutrition-and-dietetics-food-fitness-book/
Sanjay\\\'s research has been reviewed favorably by internationally reputed scientists. Some of his research has even appeared in international, peer-reviewed scientific journals. Sanjay\\\'s research on the new agreements between spirituality and science is the first ever to get published in such high-ranking journals. This is the gold standard in scientific research and a landmark of superb research on the subject of science and religion or science and spirituality. Visit http://www.SanjayCPatel.com
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Nevada Fake Moon Bay Wall is Seen.
This Video As You See & Hear it, From NASA's Public Domain Movie:
Apollo 14: Mission to Fra Mauro (1971)
Music- Symphony No.6, In D Major, 'Le Matin': Adagio - Allegro
ALL NASA FOOTAGE USED IN THIS VIDEO IS PUBLIC DOMAIN. THE USE OF ANY COPYRIGHTED MATERIAL IS USED UNDER THE GUIDELINES OF "FAIR USE" IN TITLE 17 § 107 OF THE UNITED STATES CODE. SUCH MATERIAL REMAINS THE COPYRIGHT OF THE ORIGINAL HOLDER AND IS USED HERE FOR THE PURPOSES OF EDUCATION, COMPARISON, AND CRITICISM ONLY. NO INFRINGEMENT OF COPYRIGHT IS INTENDED.
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
Milano Design Week is the setting for a collaborative, large-scale light installation by LG and Japanese designer Tokujin Yoshioka. Entitled TOKUJIN YOSHIOKA x LG: S.F_Senses of the Future, the impressive work seeks to illustrate humanity’s relationship with the natural world and to illuminate LG’s human-centric design philosophy, and will be on exhibit from 4-9 April at Superstudio Più in Milan.
The Exhibition offers visitors a feast for their senses and a taste of what the future holds by combining LG’s cutting-edge technology with Tokujin Yoshioka’s groundbreaking experimental design techniques. One part of the exhibition conveys the story of hope for the future through a commonplace object in people’s lives – the S.F chair. But these are no ordinary chairs, but ones borne of science fiction. A total of seventeen S.F chairs have been artfully ensconced with LG’s advanced OLED displays which measure only 15mm thick. The chairs are both static and dynamic because of the brilliant flashes emitted from the double-sided panels and portray a meditation on the blindingly fast speed of modern day life.
To view the multimedia release go to:
https://www.multivu.com/players/English/8074251-lg-milano-design-week/
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Johnson Controls, a global, multi-industry company, received this year’s CLEPA Innovation Award in the category “Green” for its cutting-edge work in the CAMISMA research project. Together with project partners from industry and science, the Johnson Controls team, working with a newly developed seat structure, succeeded in drastically reducing the use of steel and light alloys by replacing them with multi-material systems.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7388851-johnson-controls-camisma-lightweight/
